Nationwide Fund Advisors Glaukos Corp Transaction History
Nationwide Fund Advisors
- $918 Million
- Q2 2024
Shares
3 transactions
Others Institutions Holding GKOS
# of Institutions
303Shares Held
47MCall Options Held
75.3KPut Options Held
157K-
Black Rock Inc. New York, NY8.04MShares$1.05 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.45MShares$714 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.9MShares$248 Million4.61% of portfolio
-
State Street Corp Boston, MA1.86MShares$243 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA1.61MShares$211 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $6.23B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...